Evidence map›Paper›PMID 21959615›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2011

The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.

Wojciech J Piotrowski, Paweł Górski, Tadeusz Pietras, Wojciech Fendler, Janusz Szemraj

Open access · bronzeAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Exploring a possible association between the occurrence of theBiochemistry and biophysics reports · 2021
    Article
  3. Article
  4. HRenal failure · 2017
    Article
  5. Article
  6. Article
  7. Immunogenetics of Disease-Causing Inflammation in Sarcoidosis.Clinical reviews in allergy & immunology · 2015
    Review
  8. Molecular biomarkers in interstitial lung diseases.Molecular diagnosis & therapy · 2014
    Review
  9. Levels of plasma matrix metalloproteinases (MMP-2 and MMP-9) in response to INTEGRA® dermal regeneration template implantation.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
  10. Article
  11. The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis.Medical science monitor : international medical journal of experimental and clinical research · 2012
    Article
  12. Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis.Medical science monitor : international medical journal of experimental and clinical research · 2012
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Wojciech J PiotrowskiDivision of Pneumology and Allergy, Medical University of Lodz, Lodz, Poland.
Paweł Górski
Tadeusz Pietras
Wojciech Fendler
Janusz Szemraj
Medical University of Lodz · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIncreased activity of metalloproteinases may play a role in the initiation and propagation of inflammation in sarcoidosis, and may also be one of the factors responsible for the development of lung fibrosis. The aim of this study was to verify whether polymorphisms of MMP2 C-735T, MMP7 A-181G, MMP9 T-1702A and tissue inhibitor of metalloproteinase (TIMP)2 G-418C predispose to sarcoidosis. MATERIAL/

methodsThe study included 139 patients with sarcoidosis and 100 healthy subjects. MMPs and TIMP2 mRNA were measured in peripheral blood lysate using real-time RT-PCR. DNA for genetic polymorphism was extracted from peripheral blood by GTC method. Protein concentrations in peripheral blood lysates were measured by ELISA, and MMP2 and 9 activities in BAL fluid were estimated by gel zymography.

resultsTT genotype in MMP9 T-1702A was more frequent in sarcoidosis (p<0.0001, OR = 13.71, 95% CI 7.02-26.80) and resulted in higher expression of MMP9 mRNA (p<0.0001). No differences were found between TT and AT/AA patients in terms of radiological stage, lung function test parameters, activity markers and the presence/absence of Löfgren syndrome. There were no differences in the distribution of MMP2, MMP7 and TIMP2 polymorphisms. Messenger RNAs, as well as protein concentrations of MMP2, 7, 9, and TIMP2 were elevated in patients with sarcoidosis (p<0.0001 for each).

conclusionsThe TT homozygotes of MMP9 T-1702A genotype may be predisposed to sarcoidosis. Elevated MMP2, 7, 9, and TIMP2 mRNAs suggest their inducibility.

Indexed as

Bronchoalveolar Lavage FluidDNA PrimersEnzyme-Linked Immunosorbent AssayGenetic Predisposition to DiseaseHumansMatrix Metalloproteinase 2Matrix Metalloproteinase 7Matrix Metalloproteinase 9PolandPolymorphism, Single NucleotideReal-Time Polymerase Chain ReactionReverse Transcriptase Polymerase Chain ReactionSarcoidosisTissue Inhibitor of Metalloproteinase-2DNA PrimersMatrix Metalloproteinase 2Matrix Metalloproteinase 7Matrix Metalloproteinase 9Mmp2 protein, mouseMMP7 protein, humanMmp9 protein, mouseTIMP2 protein, humanTissue Inhibitor of Metalloproteinase-2

Identifiers

PMID21959615
PMCPMC3539463
OpenAlexW2016398571

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.